Incidence of Bleeding, Thrombosis and Transfusion Requirements in ICU Patients With COVID-19 Supported With Veno-venous Extracorporeal Membrane Oxygenation

Starting soon

Conditions studied: VV ECMO, Bleeding, Thrombosis, Transfusion Adverse Reaction, COVID-19

In brief

The investigators aim to assess the risk of bleeding and thrombo-embolic complications as well as benefit and harm of blood product transfusion and anticoagulation therapy in adult ICU patients with COVID-19 supported with V-V ECMO

Key facts

Study ID

NCT07352072

Run by

Rigshospitalet, Denmark

People needed

50

Starts

2026-01-01

Expected to finish

2026-12-01

Last updated by the study team

2026-01-29

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults
• Polymerase chain reaction (PCR) verified COVID-19 infection
• Supported with V-V ECMO in this center

You may not qualify if…

• none

Where it is running

• Department of cardiothoracic anaesthsia and intensive care 4141 — Copenhagen, Denmark

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.